The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

3 Dec 2019 07:00

RNS Number : 4153V
KRM22 PLC
03 December 2019
 

KRM22 plc

 

("KRM22" or the "Company")

 

Directorate Changes

 

KRM22 plc, (AIM: KRM) the technology and software investment company that focuses on risk management for capital markets, today announces the appointment of Steve Sparke as a Non-Executive Director of the Company. Mr Sparke will replace Matt Reed, Independent Non-Executive Director, who notified the Board of his intention to step down from the Board with immediate effect after being with the Company since its IPO in early 2018. Mr Reed is stepping down to focus on other business commitments.

 

Steve has over 30 years' experience in the Exchange Traded Derivatives ("ETD") and Commodity industry with extensive board-level experience for global ETD and Commodities organisations. He has a deep understanding of application of IT for strategic advantage and extensive expertise in optimising operational functions included technology, legal, risk and compliance.

 

Steve was recently COO of Marex Spectron where he was responsible for the firm's operating environment including operations, risk, compliance and HR. During his time at Marex, he expanded the global footprint of the organisation with new regulated entities and offices opened in New York and Hong Kong, boosted the firm's presence in Singapore and transformed the firm's operating model, facilitating growth to become Europe's largest independent commodity broker. He directed the integration of multiple businesses, including the high profile Spectron acquisition. Prior to joining Marex Spectron, he was Managing Director and Global Head of Exchange Traded Derivatives at UBS from 1994 to 2006 where he launched and led the bank's ETD Clearing and Execution business. Steve headed the Short Term Interest Rates business at SBC London Branch from 1987 to 1994.

 

Steve is a currently non-executive Chairman of FIA European Advisory Board and has held various board positions at FIA Washington and NYSE Euronext LIFFE (now ICE Europe). Steve was also non-executive director of AIM listed PATS Systems, a provider of high performance electronic trading and exchange systems for 5 years between 2006 and 2011, during which time he helped re-establish the firms growth trajectory after an extended period of declining market share.

 

With the resignation of Matt and the appointment of Steve, the Board remains comprised of four Independent Non-Executive Directors and the two Executive Directors. In addition to his role as a Non-Executive Director, Steve will replace Matt as Audit Committee Chairman.

 

Keith Todd, Executive Chairman commented:

 

"All the team would like to thank Matt for his valuable contributions since KRM22's IPO and we wish him well for the future. We are delighted to welcome Steve to the KRM22 Board. Steve brings deep industry knowledge and expertise of capital markets and will be a real asset to the Company."

 

 

The following information is disclosed in relation to Stephen Howard Sparke, age 61, pursuant to Schedule Two paragraph (g) and Rule 17 of the AIM Rules for Companies:

 

Current Directorships / Partnerships:

 

Futures Industry Association - Washington

John S Mews RTM Company Limited

Mzuzu Limited

Sparkeworld Limited

 

Previous Directorships / Partnerships (held in the past five years)

 

Nanolytics Capital Advisors Limited

Spectron Commodities Limited

Spectron Oil Limited

Spectron Services Limited

 

 

Mr Sparke currently holds 189,903 ordinary shares in the Company, representing 0.9 per cent. of the issued share capital of the Company. 

 

There is no further information to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Matthew Radley

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUGGMGPUPBPGP
Date   Source Headline
3rd Jun 20197:00 amRNSFinal Results
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes
29th Apr 20197:00 amRNSDebt Facility Secured
16th Apr 20195:30 pmRNSDirector/PDMR Shareholding
16th Apr 201910:00 amRNSKRM22 launches conduct risk training offering
11th Apr 20197:00 amRNSHolding(s) in Company
3rd Apr 20197:00 amRNSFundraising
11th Mar 20199:29 amRNSKRM22 launches Enterprise Risk Cockpit
5th Mar 20197:00 amRNSDirectorate Change
21st Jan 201911:33 amRNSResult of General Meeting
4th Jan 20197:00 amRNSNotice of GM
29th Nov 20187:00 amRNSKRM22 announces new customer contracts
6th Nov 20187:00 amRNSKRM22 announces partnership with Vector Risk
3rd Oct 201811:18 amRNSHolding(s) in Company
3rd Oct 201811:17 amRNSHolding(s) in Company
1st Oct 20181:01 pmRNSHolding(s) in Company
27th Sep 20183:52 pmRNSHolding(s) in Company
25th Sep 20185:38 pmRNSCompletion of Acquisition
25th Sep 20183:32 pmRNSAcquisition
25th Sep 20187:00 amRNSHalf-year Report
16th Aug 201810:55 amRNSChange of Registered Office
17th Jul 20187:00 amRNSSubject Matter Experts Acquired in Enterprise Risk
12th Jul 20187:00 amRNSIrisium New Customer Contract
11th Jul 20187:00 amRNSKRM22 partnership with Ascent Technologies Inc
27th Jun 20185:12 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSAcquisition
3rd May 20188:04 amRNSHolding(s) in Company
2nd May 20184:32 pmRNSDirector/PDMR Shareholding
1st May 20186:09 pmRNSHolding(s) in Company
1st May 20182:18 pmRNSHolding(s) in Company
30th Apr 20188:45 amRNSGrant of Warrant
30th Apr 20188:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.